Skip to search.
 FTSE 100 Up 0.54%

BIND Therapeutics, Inc. (BIND)

-NasdaqGS
5.39 Down 0.10(1.82%) 21:00
Add to Portfolio
Prev Close:5.49
Open:5.52
Bid:5.36 x 400
Ask:5.39 x 100
1y Target Est:16.00
Beta:N/A
Earnings Date:6 May - 11 May (Est.)
Day's Range:5.30 - 5.58
52wk Range:4.89 - 13.72
Volume:126,491
Avg Vol (3m):927,866
Market Cap:109.91m
P/E (ttm):N/A
EPS (ttm):-1.97
Div & Yield:N/A (N/A)
Trade Now
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BINDDown 1.82%109.91m
BMYDown 0.89%105.64b
PGNXDown 1.51%410.17m

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):10.74
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-2.08
Quarterly EPS Est (Mar-15) :-0.55
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

BIND Therapeutics, Inc., a clinical-stage nanomedicine platform company, develops various targeted and programmable therapeutics. It is developing Accurins that are designed with specific pharmaceutical characteristics intended to target tumors at... more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback